Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1086 | 978 | 1118 | 1128 | 1484 | 2752 |
Fund Return | 8.57% | -2.24% | 11.79% | 4.09% | 8.22% | 10.65% |
Place in category | 175 | 661 | 207 | 175 | 161 | 78 |
% in Category | 18 | 72 | 18 | 31 | 31 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund A DIST GBP | 40.25M | 12.13 | 12.03 | 21.97 | ||
Global Technology Fund W Acc GBP | 1.5B | 11.28 | 11.65 | 22.20 | ||
Global Multi Asset Income Fund I Ag | 17.68M | 1.15 | -0.49 | 5.34 | ||
EM Fund W Acc GBP | 24.08M | 7.84 | -6.16 | 5.86 | ||
China Focus Fund A DIST GBP | 7.18M | -2.48 | -1.59 | 5.60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 4.16B | 10.92 | 7.98 | 12.62 | ||
Wellington Global Health Care EquiG | 2.24B | 5.25 | 5.27 | 13.12 | ||
Adamant Medtech I GBP | 1.57B | 8.97 | 1.03 | 12.78 | ||
Pharmaceuticals Index Trust F Acc | 262.81K | 8.57 | 5.66 | 10.62 | ||
Pharmaceuticals Index Trust F Dist | 893.7Array | 8.60 | 5.63 | 10.60 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 9.27 | 593.15 | -2.10% | |
Eli Lilly | US5324571083 | 6.87 | 786.23 | -3.15% | |
Novo Nordisk B | DK0062498333 | 6.66 | 751.3 | -0.62% | |
Boston Scientific | US1011371077 | 6.47 | 87.59 | -1.33% | |
AstraZeneca | GB0009895292 | 5.23 | 10,292.0 | +1.46% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Neutral | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review